Human medicines European public assessment report (EPAR): Atosiban SUN, atosiban, Date of authorisation: 31/07/2013, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Eviplera, emtricitabine,rilpivirine,tenofovir disoproxil, Date of authorisation: 27/11/2011, Revision: 26, Status: Authorised

Consolidated advice pilots: information and training webinar for Applicants, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 17 July 2024, 15:00 (CEST) to 17 July 2024, 17:00 (CEST)

Zypadhera

FAQs: How to create, submit and withdraw a Clinical Trial Application - CTIS Training Programme - Module 10

Roles and permissions matrix summary - Authority workspace - CTIS Training Programme - Module 07

Step-by-step guide: How to respond to requests for information received during the evaluation of a Clinical Trial Application - CTIS Training Programme - Module 11

Step-by-step guide : Create, submit and withdraw a clinical trial application and nonsubstantial modifications - CTIS Training Programme - Module 10

Checklist of required fields per application type - CTIS Training Programme - Module 10

Clinical Trials Information System (CTIS) common features - CTIS Training Programme - Module 02